RespiQ is granted early-stage financing!

Exciting news: our medtech startup RespiQ is granted early stage financing ‘Vroege Fase Financiering’ (VFF) by The Netherlands Enterprise Agency (RVO)!

Grateful for this support in the development of our first device for easy food intolerance testing via breath analysis. This is a great first step for the development of the RespiQ Breathalyser platform technology, a breath diagnostics technology for the analysis of disease indicators in the breath for a large variety of diseases, ranging from our initial focus on food intolerance to an early warning system for e.g. cancer and can be used in the community from point of care to @home.

Time to Celebrate! Mira Gleisberg, Vitalii Vorkov, Wendeline Jans, Konstantin Tumashevich, Leah Putman

#innovationinhealthcare #medtech #digitalhealth #technology #startup #innovation #health #breathanalyses #genderdiversity